All-trans retinoic acid (atRA) is an active metabolite of vitamin A with antioxidant effects. There have been few reports on the effects of atRA on liver ischemia/reperfusion (I/R) injury. Here we have used a rat liver ischemia/reperfusion model to analyze the protective effect of atRA. Rats were administered with different does (5-15 mg/kg/d) of atRA intraperitoneally (i.p.) for 14 d before I/R. Partial (70%) hepatic ischemia was induced by clamping the hepatic artery, portal vein, and bile duct to the left and median lobes of the liver using a vascular clamp for 60 min, followed by 24 h of reperfusion. The serum aminotransferase (ALT and AST) and hepatic pathology were used to evaluate I/R injury. The results demonstrate that atRA pretreatment attenuates liver I/R injury by inhibiting the release of malondialdehyde (MDA) and by enhancing the activity of superoxide dismutase (SOD). To gain insight into the mechanism of the SOD up-regulation by atRA, the activity of p38 mitogenactivated protein kinase (p38MAKP) and Akt was measured. The results showed that the phosphorylation of p38MAPK and Akt paralleled the expression of manganese superoxide dismutase (MnSOD). That these activities are related was demonstrated by the addition of a p38 inhibitor which markedly decreased MnSOD levels. Taken together, our data reveal that atRA can protect liver from I/R injury by increaseing MnSOD, which is associated with an increased activity of p38MAPK and Akt.
Temporary interruption of hepatic blood flow is usually required for liver resection or liver transplantation. However, this operation with accompanying hepatic ischemia and subsequent reperfusion ultimately leads to liver injury. The liver ischemia/reperfusion (I/R) injury causes up to 10% early liver failure and increases the incidence of both acute and chronic rejection of transplantation. 1, 2) It has been shown that oxygen free radicals are involved in liver damage following I/R.
3) Oxygen-free radical formation following re-oxidation may initiate the cascade of cell injury, necrosis/apoptosis, and subsequent inflammatory infiltration. [4] [5] [6] All of these free radical pathways can ultimately affect liver remodeling following injury through the production of cytokines and growth factors. Therefore, reducing oxidative stress has been traditionally thought to be an effective therapeutic approach in the protection from liver I/R injury.
The source of oxygen-free radical formation after liver I/R injury remains unclear and may involve Kupffer cells, endothelial cells, hepatocytes and neutrophils. One important member of the oxygen-free radicals, shown to be involved in I/R injury, is superoxide. 7) Several mechanisms have been proposed for the generation of superoxide during the phase of I/R. These mechanisms include the xanthine/xanthine oxidase system, mitochondrial respiration, receptor-induced oxygen-free radical generation by pathways such as Rac1/ nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, and inflammatory cell production of superoxide. [8] [9] [10] [11] Nonetheless, endogenous antioxidant systems have been found to be a defense against superoxide production. These antioxidant systems include superoxide dismutases (SODs) such as Cu/Zn-SOD and manganese superoxide dismutase (MnSOD), which reside in the cytoplasm or mitochondria respectively. 12) MnSOD is generated by respiratory chain activity and is an essential primary antioxidant enzyme that converts superoxide radical to hydrogen peroxide within the mitochondrial matrix. 13) Numerous reports have demonstrated a protective role of MnSOD in liver I/R injury and its partial deficiency (Sod2 ϩ/Ϫ ) exacerbates cerebral infarction after I/R. 14) Overexpression of MnSOD by genetic modification significantly attenuates myocardial necrosis after myocardial ischemia and reperfusion. 15) Additionally, it was also shown that in vivo adenoviral gene transfer of MnSOD is an efficient approach to enhance the antioxidant protection for cardiomyocytes after I/R. 16 ) Therefore, it is reasonable to speculate that it can protect against I/R injury in the liver and other organs by increasing the levels of MnSOD in vivo.
Many drugs or agents have been evaluated in preventing or blocking oxidation after I/R, but the outcomes were not consistent. All-trans retinoic acid (atRA), an active and natural derivative of vitamin A, has been reported to possess various biological activities including anti-cancer, anti-inflammatory and antioxidant properties. AtRA has been widely used in the treatment of acute promyelocytic leukemia and inflammatory disorders. [17] [18] [19] Although many studies have focused on its anti-cancer and anti-inflammatory properties, [20] [21] [22] [23] Ahlemeyer's group has found that atRA has a strong antioxidant property, which can enhance the oxygen free radical scavenger SOD and reduce the generation of oxidative stress levels. 16) More recently, Kinsley's group confirmed that atRA can induce MnSOD in vitro. 24) It is still unclear whether the antioxidant property, or some other effect, following administration of atRA can protect against I/R injury in vivo. In the present study, we show that atRA pretreatment can protect against liver ischemia/reperfusion injury and that atRA exerts the protective effects by increasing the levels of MnSOD.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (200-250 g, SLAC Experimental Animal Co., Shanghai, China) were housed in controlled environmental conditions with a 12-h light-dark cycle, with free access to standard rodent diet and water. The rats were not fasted before the operation. The experiments were conducted in accordance with guidelines approved by the Chinese Association of Laboratory Animal Care, and the standards for animal use and care set by the Institutional Animal Care Committee.
Surgical Procedure and Experimental Design Male Sprague-Dawley rats were anesthetized by inhalation of ether. After shaving and disinfecting the abdomen with betadine, a median incision was performed. Ischemia of the left and median lobes of the liver (70%) was induced for 60 min by placement of an atraumatic bulldog clamp across the pedicles of the left portal vein, hepatic artery and bile duct. 25) After removal of the clamp, the abdomen was closed with interrupted sutures and the anesthesia was withdrawn. Rats were sacrificed after 24 h reperfusion. All animals were divided into four groups. A sham-operated group, which underwent the same procedure of laparotomy without I/R (Sham, nϭ6); an I/R group of animals which underwent 60 min of partial no-flow ischemia and 24 h reperfusion without treatment (I/R, nϭ6). A low dose atRA (5 mg/kg) pretreated group, where animals were administrated atRA (intraperitoneally (i.p.) 5 mg/kg/d for 14 d) and I/R operation was done at day 14 (nϭ6) and a high dose atRA (15 mg/kg) pretreated group, where animals received atRA (i.p. 15 mg/ kg/d for 14 d) and I/R operated in the same protocol (nϭ6). Figure 1 shows the experimental steps of the various groups. AtRA was purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.) and diluted in dimethyl sulfoxide (DMSO) to a concentration of 100 mg/ml.
p38 Mitogen-Activated Protein Kinase (p38MAPK) Inhibitor Administration SB203580 (p38MAPK inhibitor, p38i) was purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.) and diluted in DMSO to a concentration of 5 mg/ml. The p38i was i.p. injected every other day for 14 d before I/R operation.
Serum Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) Levels by Biochemical Test Blood samples were collected at 24 h after reperfusion in each group. Serum levels of ALT and AST were detected by an automated chemical analyzer (Olympus Automated Chemistry Analyzer AU5400, Japan).
Histopathologic Study The medial and left lobes of the liver were sampled, with part being fixed with 10% neutral formaldehyde at once. Paraffin-embedded rat liver specimens were sectioned at 4 mm and stained with hematoxylin and eosin (HE). Ultrathin sections were fixed in 2.5% dialdehyde, stained with aqueous uranyl acetate, dehydrated in ethanol, embedded in epoxy resin, and read with a light microscope. The sections were used for histopathological analysis. Sections were scored from 0-4 for sinusoidal congestion, vacuolization of hepatocyte cytoplasm, and parenchymal necrosis as described by Suzuki et al. 26) (Table 1) . Liver Tissue Homogenate Malondialdehyde (MDA) and SOD Assay MDA and SOD were used as markers to assess the oxidation-reduction status of the liver tissues. The levels of tissue homogenate MDA were measured using kits and performed according to the manufacturer's directions (Jiangcheng Biotechnology, Nanjing, China). The results were expressed in nmol MDA per milligram of tissue homogenate. SOD activity was measured in the liver using an indirect competition assay between SOD and the indicator compound, nitroblue tetrazolium (NBT), for superoxide produced by xanthine/xanthine oxidase according to the method of Spitz and Oberley. 27) One SOD activity unit was defined as the enzyme amount causing 50% inhibition in 1 ml reaction solution per milligram tissue protein. The data was expressed as U/mg protein activity units.
Western Blotting The liver tissues were homogenized in 200 ml extraction protein buffer. After incubation for 20 min on ice, the buffer was centrifuged (10000ϫg for 10 min at 4°C) and the protein concentration in the extracts was determined using the Bradford assay. After heat treatment for 5 min in boiling water, proteins (80-100 mg) were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes (Sunshine Biotechnology, China). These membranes were blocked with (5% wt/vol) skim milk powder-Tris-buffered saline (TBS) with 0.1% Tween 20 (TBS-T) at 4°C overnight. The membranes were then incubated for 4 h at room temperature with rabbit anti-MnSOD (1 : 4000), anti-phosphop38MAPK (1 : 4000) or anti-phospho-Akt antibody (1 : 4000) (Abcam, U.S.A.). Following three washes with TBS-T, the membranes were then incubated for 2 h at room temperature with goat-anti-rabbit peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, CA, U.S.A.). The final results were obtained by exposure to Kodak film.
Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Total RNA was extracted from liver tissue samples frozen at Ϫ80°C using the TRIzol reagent according to the manufacturer's protocol (Invitrogen), and RNA concentration was determined by spectrophotometer. The synthesis of cDNA was performed according to the manufacturer's instructions with a reverse transcriptase kit (TaKaRa Biotechnology Co., Ltd.). Real-time PCR was carried out using an ABI Prism 7300 (Applied Biosystems). The real- time PCR was processed with a total volume of 25 ml containing 12.5 ml SYBR Green premix Ex Taq TM II (2ϫ), 1 ml sense primers, 1 ml anti-sense primers, 2 ml cDNA template, and 8.5 ml dH 2 O. The following cycling conditions were used in the real-time PCR: 40 cycles at 95°C for 30 s, 60°C for 31 s and extension at 72°C for 30 s. The measurements of each sample were performed in triplicate. We analyzed the results using Applied Biosystems software. Data of MnSOD mRNA copies were expressed as the relative quantification (RQ), and RQ was calculated using the 2-DDCt method, where DDCtϭDCt (observed)ϪDCt (control) and DCtϭCt (gene)Ϫ Ct (GAPDH).
28) The primer sequences used for RT-PCR were as follows: MnSOD (149 bp), 5Ј-GGC CAA GGG AGA TGT TAC AA-3Ј and 5Ј-CCA CAG GCC TTA TTC CAC TG-3Ј; GAPDH (143 bp), 5Ј-GCT GGT CAT CAA CGG GAA A-3Ј and 5Ј-ACG CCA GTA GAC TCC ACG AC-3Ј. The GAPDH was used as endogenous control.
Statistical Analysis All data are expressed as meanϮ S.E.M. Differences between experimental groups were statistically analyzed using an ANOVA and Bonferroni test for unpaired data when appropriate. Differences were considered statistically significant at probability level pϽ0.05.
RESULTS
AtRA Attenuates the Liver Injury from I/R Serum ALT and AST levels in each group are shown in Fig. 2 . ALT and AST levels were increased markedly in I/R group after 24 h reperfusion compared to the sham group (pϽ0.05). Conversely, when pretreated with atRA (5, 15 mg/kg) the ALT and AST levels were markedly decreased compared with I/R group (pϽ0.05), especially with high dose atRA (15 mg/kg). AtRA itself is reported to be hepatotoxic which, with the potential for chemical-induced hepatotoxicity, could be problematic. 29, 30) Here we found that ALT and AST levels were compararble to those of the sham group after high dose atRA (15 mg/kg) treatment for 14 d (Fig. 2) . This demonstrates that atRA can significantly ameliorate liver function after liver I/R injury without any hepatotoxic effect. Pathological examination can reflect directly the levels of liver tissue damage. The histological parameters observed in the a (sham), b (I/R), c (I/Rϩ5 mg/kg atRA) and d (I/Rϩ15 mg/kg atRA) are shown in Fig. 3A , and they scored as 1.67Ϯ0.82, 8.50Ϯ1.05, 3.17Ϯ1.17 and 2.33Ϯ1.03 respectively (Fig.  3B) . The histological score reveals significant differences between sham and I/R group and between the I/R and atRA administration group. In addition, the 15 mg/kg atRA pretreatment group had a lower score than the 5 mg/kg group. This indicates that atRA can significantly improve I/R-induced pathological changes.
The MDA Levels and SOD Activities in Liver Tissue MDA, an index of lipid peroxidation which reflects the levels of the oxygen free radicals, was significantly increased after reperfusion in I/R group compared with the sham group whereas MDA was significantly decreased in both atRA pretreatment groups (pϽ0.05), especially with high dose atRA, and p38i could lighten the role of atRA (Fig. 4A) . Decreased activity of SOD was found in the I/R group as compared with the sham group. Interestingly, the activity of SOD was significantly increased in both pretreatment groups compared with I/R control group (pϽ0.05), and was even higher than the sham group. However, the atRA-increased SOD activity was inhibited by p38i (Fig. 4B) .
MnSOD, p-p38MAPK and p-Akt Protein Expression
The expression of MnSOD, p-p38MAPK and p-Akt was analyzed by Western blotting. In the present study, we firstly investigated effects of atRA on expression of MnSOD, pp38MAPK and p-Akt in the livers of normal rats. Figure 5A shows that atRA can significantly increase expression of MnSOD, p-p38MAPK and p-Akt in the liver of normal rats. We further assessed the effects of atRA on MnSOD, pp38MAPK and p-Akt in the livers of I/R model rats. As shown in Fig. 5B , after I/R, the expression of MnSOD protein was significantly reduced compared to the sham animals, nonetheless those pretreated with atRA were noticably increased in their expression of MnSOD. The level of MnSOD protein in high dose atRA group was especially high. The expression of p-p38MAPK and p-Akt proteins paralleled those of the MnSOD in atRA pretreated groups.
MnSOD mRNA Levels Increased by High Dose AtRA Pretreated The relative mRNA levels of MnSOD in the liver tissue after I/R were analyzed by real-time RT-PCR. Figure 6 shows that I/R significantly reduced the levels of MnSOD mRNA compared to the normal rats but not in the atRA pretreatment groups. In fact, the mRNA levels were about 3.5 times higher in 15 mg/kg pretreatment group in comparison with the I/R group. When p38i was injected with atRA before I/R, the MnSOD mRNA level was downregulated. The MDA levels and SOD activity of liver homogenate were measured using kits, as decribed in Materials and Methods. Results are the meanϮS.E.M. values of six rats. pϽ0.05 is considered significant difference. Equal amounts (80 mg) of total cell lysate proteins were separated in NuPAGE 4-12% gradient SDS-PAGE gels using a MOP buffering system. After protein was transferred into PVDF membrane, proteins of interest were detected by specific antibodies (anti-MnSOD, anti-phospho-p38MAPK or anti-phospho-Akt antibodies). Representative of MnSOD, p-p38MAPK and p-Akt profiles for each of the different groups is shown. 
DISCUSSION
Bleeding is a common complication of liver surgery. To reduce haemorrhage, temporary interruption of hepatic inflow blood is necessary during liver resection and liver transplantation. The interruption of blood flow to the liver and the subsequent reperfusion can cause significant liver injury and dysfunction. 1, 2) Reactive oxygen species (ROS) generated upon reperfusion contributes to the pathophysiology of I/R injury of the liver. [31] [32] [33] Therefore, therapies targeting oxidants may be useful to prevent acute organ injury induced by oxidative stress.
Retinol (Vitamin A) (all-trans retinol) and its metabolites, all-trans-and cis-retinoic acid and 11-cis-retinal, are involved in processes such as vision, reproduction, growth development and immune function. AtRA and 9-cis-retinoic acids, are potent regulators of gene transcription, and play important roles in regulating cell proliferation and differentiation. Retinoid-binding protein is a soluble protein that is found in a variety of tissues and that associates with a specific retinoid. AtRA is found intracellularly bound to one of the two cellular retinoic acid-binding protein isoforms. High dose atRA has hepatotoxic effects. Here we treated rats with different doses of atRA (5-15 mg/kg) for 14 d and found no evidence of liver injury (Fig. 2) .
In the present study, elevated levels of ALT and AST confirmed that liver I/R injury can cause serious liver damage. Interestingly, atRA pretreatment significantly ameliorated the liver injury after I/R, especially with the 15 mg/kg pretreatment (Fig. 2) . Histological examination supported this finding, with there being sinusoidal congestion, apparent edema, vacuolization, degeneration and necrosis of the liver in I/R group (Suzuki score: 8.50Ϯ1.05) (Fig. 3) . After atRA pretreatment these morphological changes improved, especially in high dose atRA group (Suzuki score: 2.33Ϯ1.03) (Fig. 3 ). Our results demonstrate that I/R causes significant liver damage, and that atRA pretreatment can provide a protective effect against hepatic I/R injury in a dose-dependent manner.
I/R injury is a complex process which includes oxygen free radical production, activation of inflammatory cells, calcium overload as well as other factors. [31] [32] [33] Excessive oxygen free radicals production is a significant contributor to I/R injury.
31) The source of the oxygen-free radicals' formation after liver I/R may involve Kupffer cells, endothelials cells, hepatocytes and neutrophils. [34] [35] [36] The abnormal excessive production of oxygen free radicals results in lipid peroxidation which plays an important role in the degree of liver damage resulting from I/R. 37) Lipid peroxidation induces both structural and functional injury to the cell organelle membranes. The MDA is the end-product of lipid peroxidation. 38) Thus, the tissue MDA level can be used as a criterion for the degree of lipid peroxidation, and reflects the level of tissue oxygen free radicals. In the present study, the I/R group had a significantly higher MDA level than the sham group, and atRA pretreatment groups had a significantly lower MDA level compared with I/R group, especially in 15 mg/kg atRA pretreatment group (Fig. 4A ). These results demonstrate that atRA can significantly reduce the MDA level after reperfusion and indicates that atRA can reduce the level of free radicals.
Lipid peroxidation and production of oxygen free radicals are regulated by various intracellular and extracellular antioxidant enzymes. An important contributing factor to the increase of oxygen free radical levels after I/R is the reduction of antioxidant enzyme activity. 39, 40) It is well known that SOD, an important antioxidant enzyme, is decreased after I/R. 40) It has been reported that intravenous treatment with SOD resulted in reduced apoptotic cell death and oxygen free radical production after ischemia/reperfusion in the rat. 41, 42) In the present study, the activity of SOD was found to be significantly reduced after heaptic I/R injury, whereas this was reversed by pretreatment with atRA. MnSOD is the major antioxidant enzyme of the SOD antioxidant system and is essential for life. Munusamy and MacMillan-Crow reported that mice expressing only 50% of the normal complement of MnSOD demonstrated an increased susceptibility to oxidative stress and severe mitochondrial dysfunction resulting from the elevation of oxygen free radicals. 43) Furthermore, the over expression of MnSOD enzyme renders the cell and tissues resistant to I/R injury. 44) It has been reported that the enhancement of tissue antioxidant capacity by the over expressing of Mn-SOD protected against oxidative stress-induced tissue injury in the brain. 45, 46) In the present study, atRA pretreatment significantly enhanced MnSOD activity and expression after liver I/R, and downregulated postischemia oxygen free radical formation.
AtRA is a common clinical drug for acute myeloblastic leukemia (AML), which has anti-neoplastic and immunomodulatory actions. [17] [18] [19] Recently, atRA has been reported to increase MnSOD expression in vitro. atRA can increase MnSOD protein level in acute myeloblastic leukemia cells, in addition, Mäntymaa P group detected MnSOD gene as a retinoid-responsive marker of neuroblastoma cell. 24, 47) In our study, we examined the total SOD activity in liver tissue by a SOD activity kit. Figure 3B shows that atRA pretreatment can significantly increase SOD activity compared to the I/R group, which was consistent with the MDA levels in these groups. AtRA pretreatment can also significantly increase the expression of MnSOD protein in a dose-dependent manner. In addition, real-time polymerase chain reaction confirmed this effect of atRA (Fig. 6 ). Taken together, these results demonstrate that atRA pretreatment can upregulate MnSOD mRNA, protein, and activity in rats. Increased expression and activity of liver MnSOD may exert its potential protective role in I/R injury through scavenging oxygen free radical after reperfusion. However, the specific mechanism of atRA-mediated MnSOD upregulation needs further study. It has been reported that the levels of MnSOD protein (Ͼ95% reduction) and SOD enzyme activity are heavily curtailed by the p38MAPK inhibitor SB203580. 48) It has been observed that p38 MAPK activation seems to be an important step in the signal transduction cascade of acute ischemic preconditioning. 49, 50) It has been also been reported that the upregulation of p38MAPK initiated the activation of Akt which subsequently induces MnSOD. 48) In the present study, we also found that changes in the levels of MnSOD paralleled changes in the levels of p-p38MAPK and p-Akt following atRA pretreatment (Fig. 5) . In addition, when p38i was administrated with atRA, the MnSOD level was noticably decreased compared to the atRA treated group (Fig. 6) . Thus, this suggests that SOD up-regulation by atRA may depend on the p38MAPK/Akt signaling pathway (Fig. 7) . Recent studies have demonstrated that MnSOD expression may be mediated by a number of transcription factors, 24, 48, [51] [52] [53] but the elements that control the transcription of MnSOD by atRA remain to be elucidated.
In conclusion, here we have demonstrated that the atRA pretreatment can protect against heaptic I/R injury. Our data also reveal that atRA can protect liver from I/R injury by increaseing MnSOD, which is associated with an increased activity of p38MAPK and Akt. Thus, atRA has therapeutic potential in the prevention of I/R injury which could be tested in a clinical trial. Vol. 33, No. 5 AtRA pretreatment is responsible for the augmentation of p38MAPK which in turn phosphorylates Akt. Phosphorylated Akt functionally increases MnSOD production, which can alleviate liver I/R injury by reducing oxygen-free radicals.
